Evidence map›Paper›PMID 42315778›Full record

ArticleSurgical endoscopy2026

Rise of robotic sleeve gastrectomy fails to show improved outcomes versus laparoscopy analysis of 9 years of MBSAQIP data including over half a million patients.

Yeisson Rivero-Moreno, Juan Zubillaga-Gutierrez, Omar Bellorin

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yeisson Rivero-MorenoDepartment of Surgery, Montefiore Medical Center, Bronx, NY, USA. Yeissonmbi@hotmail.com.ORCID http://orcid.org/0000-0002-9077-1460
Juan Zubillaga-GutierrezUniversidad Central de Venezuela, Caracas, Venezuela.
Omar BellorinDepartment of Minimally Invasive Surgery, Holy Name Medical Center, Teaneck, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSleeve gastrectomy (SG) is the most common bariatric procedure worldwide. While robotic sleeve gastrectomy (RSG) offers potential technical advantages over the laparoscopic approach (LSG), concerns remain regarding its impact on surgical outcomes and temporal trends. This study aimed to compare the frequency and risk of postoperative outcomes between RSG and LSG.

methodsA retrospective analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database was conducted, including patients from 2015 to 2023 who underwent primary SG without concomitant procedures. The primary outcome was overall postoperative complications (OPC). Secondary outcomes included staple line complications (SLC: gastrointestinal bleeding and leaks) and unplanned healthcare utilization (UHCU). Temporal trends were analyzed through linear correlation analysis (R

resultsA total of 567,199 patients were included, of whom 81.3% (n = 461,343) underwent LSG and 18.7% (n = 105,856) underwent RSG. Most patients were female (79.7%, n = 452,009) with a mean age of 42.4 ± 11.8 years and a mean BMI of 45.3 ± 7.9 kg/m

conclusionsRobotic sleeve gastrectomy was associated with a higher frequency of OPC and UHCU, although the absolute risk increase was small. No significant differences were observed in SLC. Additionally, an increasing trend in OPC was noted in recent years, which was more pronounced in the RSG group.

Indexed as

Bariatric SurgeryGastrectomyLaparoscopyObesity, MorbidPostoperative ComplicationsRobotic Surgical ProceduresAdultFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeRobotic surgerySleeve gastrectomySurgical outcomes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.